AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
Abstract Pompe disease (PD) is a metabolic myopathy due to acid alpha-glucosidase deficiency and characterized by extensive glycogen storage and impaired autophagy. We previously showed that modulation of autophagy and lysosomal exocytosis by overexpression of the transcription factor EB (TFEB) gene...
Guardado en:
Autores principales: | Francesca Gatto, Barbara Rossi, Antonietta Tarallo, Elena Polishchuk, Roman Polishchuk, Alessandra Carrella, Edoardo Nusco, Filomena Grazia Alvino, Francesca Iacobellis, Elvira De Leonibus, Alberto Auricchio, Graciana Diez-Roux, Andrea Ballabio, Giancarlo Parenti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/678d39e7a19b43b9866916b4208c4792 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Antonietta Tarallo, et al.
Publicado: (2021) -
mTOR-dependent phosphorylation controls TFEB nuclear export
por: Gennaro Napolitano, et al.
Publicado: (2018) -
Structure of human lysosomal acid α-glucosidase–a guide for the treatment of Pompe disease
por: Véronique Roig-Zamboni, et al.
Publicado: (2017) -
Molecular study of Pompe disease in Egyptian infants
por: Mona Essawi, et al.
Publicado: (2021) -
TFEB regulates murine liver cell fate during development and regeneration
por: Nunzia Pastore, et al.
Publicado: (2020)